We carry out cutting edge research on molecular mechanisms of DNA repair and replication stress. We study causes and consequences of genomic instability, a major driving force for tumorigenesis, and aim to identify new targets for cancer therapy.

We use animal models and organoids to study mechanisms of tumorigenesis and immune responses induced by pathogens or chronic tissue damage. We synergise with clinical researchers to explore potential clinical applications of our findings.

We train and educate the next generation of scientists in cancer biology by coordinating Master and PhD Programs and organising seminars with high-quality speakers.